Lilly Acquires Curevo, LimmaTech and Vaccine Company
INDIANAPOLIS, United States, May 26, 2026 Eli Lilly and Company has announced three major biotechnology acquisitions aimed at significantly...
Mergers & Acquisitions for New Therapy
CVC and GBL Launch €10.7B Bid to Take Recordati Private
Milan, Italy, May 22, 2026 A consortium led by CVC Capital Partners IX and Groupe Bruxelles Lambert (GBL) has...
Gilead Expands Oncology Portfolio With Tubulis Deal
Foster City, California, USA – May 22, 2026 Gilead Sciences, Inc. announced the successful completion of its acquisition of...
Lilly Acquires Engage Bio for Genetic Medicines
SAN CARLOS, Calif., May 22, 2026 Eli Lilly and Company has acquired Engage Bio, a preclinical biotechnology company focused...
Medtronic to Acquire SPR Therapeutics for Pain Care
GALWAY, Ireland, May 20, 2026 Medtronic plc has announced its intent to acquire SPR Therapeutics, Inc. in a deal...
SERB and Hansa Biopharma Strengthen Rare Disease Portfolio With Idefirix Agreement
BRUSSELS, Belgium, May 19, 2026 SERB Pharmaceuticals and Hansa Biopharma have announced a strategic €115 million licensing agreement granting...
Regeneron Expands Precision Medicine Pipeline With $2.3B Parabilis Collaboration
TARRYTOWN, N.Y., May 18, 2026 Regeneron Pharmaceuticals has announced a major strategic collaboration with Parabilis Medicines valued at up...
Zydus Lifesciences to Acquire Assertio in $166.4 Million Deal
LAKE FOREST, Ill., May 13, 2026 Assertio Holdings announced that it has entered into a definitive agreement to be...
Fosun Pharma Signs Global Option Deal for AriBio’s AR1001
SHANGHAI and SEONGNAM-SI, South Korea, May 13, 2026 Fosun Pharma and AriBio announced the signing of an exclusive global...
Boehringer Expands Immunology Pipeline With Immunitas Deal
INGELHEIM, Germany and WALTHAM, Mass., May 12, 2026 Boehringer Ingelheim has entered into a global licensing agreement with Immunitas...